Investigating the Efficacy of Combining Virtual Reality-Based Mirror Therapy (VRMT) and Transcranial Direct Current Stimulation (tDCS) to Improve Upper Limb Recovery in Patients with Stroke
NCT ID: NCT06764797
Last Updated: 2025-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
300 participants
INTERVENTIONAL
2023-09-19
2025-07-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigating the Feasibility of Combining Virtual Reality and Bilateral Transcranial Direct Stimulation to Improve Upper Limb Recovery in Patients With Stroke
NCT07288385
Combining tDCS With VR-based Motor Training in Stroke
NCT03144102
Mixed Reality and Virtual Reality Technology With Mirror Therapy for Stroke Rehabilitation
NCT05903235
Effects of Virtual Reality Multisensory Cooperative Task-Oriented Mirror Therapy
NCT07139379
Recovering Arm Function in Chronic Post-stroke Patients Using Combined HD-tDCS and Virtual Reality Therapy
NCT04291573
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The participants will be randomly assigned into one of the four groups: (1) the anodal tDCS + VRMT group, (2) the anodal tDCS alone group, (3) the VRMT alone with sham tDCS group, and (4) the CPT with sham tDCS group. All groups will receive CPT as part of the treatment. Functional scales will be used before and after the intervention to assess upper motor functions. These measures include the Fugl-Meyer Assessment, Wolf Motor Function Test, Box and Block Test, Nine-Hole Pegboard Test, and Stroke Impact Scale-16 (SIS-16). In addition, physiological measures such as transcranial magnetic stimulation (TMS) and task-based fMRI.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
anodal tDCS combined with VRMT
20 minutes of anodal tDCS combined with 45 minutes of VRMT
Transcranial Direct Current Stimulation compined with virtual reality based mirror therapy
20 minutes of tDCS during 45 minutes of VRMT games.
Anodal tDCS alone
20 minutes of anodal tDCS alone
Transcranial Direct Current Stimulation
tDCS will be used during the sessions. The anodal tDCS (2 mA) will be applied for 20 minutes. Continuous, direct currents. The anodal electrode will be positioned over the ipsilesional primary motor cortex (M1) (C3 or C4, international 10-20 system) of the affected hemisphere and the cathodal electrode over the contralateral orbit.
VRMT alone, Sham tDCS
45 minutes of VRMT alone, For the sham-tDCS, the current flow will be terminated after 30 seconds.
Virtual reality
The VRMT group will receive VRMT game-based training using their non-affected upper limb. using a semi-immersive motion-tracking device.
Conventional Physical therapy alone, Sham tDCS
45 minutes of conventional physical therapy, For the sham-tDCS, the current flow will be terminated after 30 seconds.
Conventional physical therapy
45 minutes of conventional physical therapy with sham tDCS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial Direct Current Stimulation
tDCS will be used during the sessions. The anodal tDCS (2 mA) will be applied for 20 minutes. Continuous, direct currents. The anodal electrode will be positioned over the ipsilesional primary motor cortex (M1) (C3 or C4, international 10-20 system) of the affected hemisphere and the cathodal electrode over the contralateral orbit.
Virtual reality
The VRMT group will receive VRMT game-based training using their non-affected upper limb. using a semi-immersive motion-tracking device.
Transcranial Direct Current Stimulation compined with virtual reality based mirror therapy
20 minutes of tDCS during 45 minutes of VRMT games.
Conventional physical therapy
45 minutes of conventional physical therapy with sham tDCS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stroke patients with unilateral cerebral infarction or hemorrhage, more than three months following the stroke.
* Adequate cognitive ability to follow instructions (The Arabic version of the Mini-Mental State Examination scores \> 24).
* Modified Ashworth scale score \< 3.
* Fugl-Meyer Assessment (FMA) score of 10-58 indicating moderate-to-severe arm impairment.
Exclusion Criteria
* Wernicke's aphasia, or global aphasia, leads to difficulty following instructions.
* Any contraindication to NIBS.
* Other neurological conditions or participation in another study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King Fahad Medical City
OTHER_GOV
King Saud Medical City
OTHER_GOV
King Saud University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Alaa Albishi
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alaa M. Albishi, Doctor of Philosophy
Role: PRINCIPAL_INVESTIGATOR
King Saud University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
King fahad medical city
Riyadh, Riyadh Region, Saudi Arabia
King Khalid University Hospital
Riyadh, Riyadh Region, Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Not funded
Identifier Type: OTHER
Identifier Source: secondary_id
E-23-7496
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.